0K9A.F · FSD Pharma Inc

-

Please sign in to comment on 0K9A.F

1 Comment

Admin

4 years ago

FSD Pharma Inc is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.

From a valuation standpoint, the stock is 93.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 80.8.

FSD Pharma Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.

Its net income has increased by 75.7% to $-5M since the same quarter in the previous year.

Finally, its free cash flow grew by 9.2% to $-4M since the same quarter in the previous year.

Based on the above factors, FSD Pharma Inc gets an overall score of 3/5.

Exchange	F
CurrencyCode	EUR
ISIN	CA35954B2066
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

PE Ratio	None
Target Price	None
Market Cap	47M
Beta	1.18
Dividend Yield	0.0%

ABOUT

FSD Pharma Inc

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

0K9A.F · FSD Pharma Inc

-

FSD Pharma Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest FSD Pharma Inc using a moving average strategy